The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
Abstract
INTRODUCTION: The hemagglutination inhibition (HI) titer of 1:40, which has been recognized as an immunologic correlate corresponding to a 50% reduction in the risk of contracting influenza, is based on studies in adults. Neither seasonal nor challenge-based correlates have been evaluated in children. METHODS: A total of 4707 influenza vaccine-naive healthy children 6 to 72 months old were randomized in a ratio of 2:2:1 to receive 2 doses of MF-59-adjuvanted influenza vaccine (Novartis Vaccines), trivalent inactivated influenza vaccine subunit (trivalent inactivated influenza vaccine control, GSK), or a saline placebo during the 2007 to 2008 and 2008 to 2009 influenza seasons. The second dose was given 30 days after dose 1. Clinical influenza-like illnesses cases identified by active surveillance were confirmed by reverse transcription polymerase chain reaction testing for influenza. Vaccine immunogenicity 50 days after dose 1 was evaluated in a subset of 777 children. RESULTS: Immunogenicity and efficacy results for H3N2 were evaluated against the Prentice criteria, which confirmed that the immunogenicity results warranted estimation of an immunologic correlate. We then used the Dunning model fitting the H3N2 antibody titers at day 50 and the influenza cases observed in the immunogenicity subset to estimate a correlate of protection. This analysis revealed that a cutoff HI titer of 1:110 was associated with the conventional 50% clinical protection rate against infection during the entire season, and titers of 1:215, 1:330, and 1:629 predicated protection rates of 70%, 80%, and 90%, respectively. The conventional adult HI titer of 1:40 was only associated with 22% protection. CONCLUSIONS: The use of the 1:40 HI adult correlate of protection is not appropriate when evaluating influenza vaccines in children. Although a cutoff of 1:110 may be used to predict the conventional 50% clinical protection rate, a titer of 1:330 would predict an 80% protective level, which would seem to be more desirable from a public health perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Self-citationSurrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children
Izurieta, H. S., Thompson, W. W., Kramarz, P., Shay, D. K., Davis, R. L., DeStefano, F., Black, S., Shinefield, H., & Fukuda, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001273420402 · Cited by 1,012
Self-citationHobson, D., Curry, R. L., Beare, A. S., & Ward-Gardner, A. (1972) · Epidemiology and Infection · doi:10.1017/s0022172400022610 · Cited by 1,002
Kayhty, R., Peltola, H., Karanko, V., & Makela, P. H. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.6.1100 · Cited by 542
Jódar, L., Butler, J., Carlone, G., Dagan, R., Goldblatt, D., Käyhty, H., Klugman, K., Plikaytis, B., Siber, G., Kohberger, R., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00230-5 · Cited by 388
Khurana, S., Verma, N., Yewdell, J. W., Hilbert, A. K., Castellino, F., Lattanzi, M., Del Giudice, G., Rappuoli, R., & Golding, H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002336 · Cited by 356
Self-citationImmunologic correlates of protection induced by vaccination
PLOTKIN, S. A. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200101000-00013 · Cited by 242
INFLUENZAVIRUS INFECTIONS IN SEATTLE FAMILIES, 1975–1979
FOX, J. P., COONEY, M. K., HALL, C. E., & FOY, H. M. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113408 · Cited by 196
Circulating Antitoxin at the Onset of Diphtheria in 425 Patients
Ipsen, J. (1946) · The Journal of Immunology · doi:10.4049/jimmunol.54.4.325 · Cited by 148
Cited by
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
Influenza vaccination of pregnant women and protection of their infants
Madhi, S. A., Cutland, C. L., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., Adrian, P. V., van Niekerk, N., Treurnicht, F., Ortiz, J. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401480 · Cited by 556
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Muik, A., Wallisch, A.-K., Sänger, B., Swanson, K. A., Mühl, J., Chen, W., Cai, H., Sarkar, R., Türeci, Ö., Dormitzer, P. R., et al. (2021) · doi:10.1101/2021.01.18.426984 · Cited by 515
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
Muik, A., Wallisch, A.-K., Sänger, B., Swanson, K. A., Mühl, J., Chen, W., Cai, H., Maurus, D., Sarkar, R., Türeci, Ö., et al. (2021) · Science · doi:10.1126/science.abg6105 · Cited by 515
Memoli, M. J., Shaw, P. A., Han, A., Czajkowski, L., Reed, S., Athota, R., Bristol, T., Fargis, S., Risos, K., Powers, J. H., et al. (2016) · mBio · doi:10.1128/mbio.00417-16 · Cited by 374
Metadata
- Authors
- Black, S., Nicolay, U., Vesikari, T., Knuf, M., Del Giudice, G., Della Cioppa, G., Tsai, T., Clemens, R., & Rappuoli, R.
- Venue
- Pediatric Infectious Disease Journal
- Published
- 2011-12
- Volume
- 30
- Issue
- 12
- Pages
- 1081-1085
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W1963590894
- Cited by
- 334
- References
- 17
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children. https://app.cochat.ai/papers/10.1097/inf.0b013e3182367662
- The paper
- Black, S., Nicolay, U., Vesikari, T., Knuf, M., Del Giudice, G., Della Cioppa, G., Tsai, T., Clemens, R., & Rappuoli, R. (2011). Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children. Pediatric Infectious Disease Journal. https://doi.org/10.1097/inf.0b013e3182367662
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.